Détection précoce du cancer de la prostate : vers un nouveau paradigme ?

The diagnostic strategy for PCa well codified and assessed by digital rectal examination, testing multiparametric MRI, which may or not lead to biopsies. formal benefit of organized screening, studied more than years ago at an international scale all incomers, demonstrated. However, therapeutic modalities have evolved since the pivotal studies. contribution MRI targeted biopsies, widespread use unsignificant PCa, improvement surgical radiotherapy… allowed better selection patients strengthened interest individualized approach, reducing risk overtreatment. Aiming enhance coverage access screening population, European recently promoted evaluation strategy, including MRI. lack programs has become detrimental must shift towards early detection policy adapted each individual.